Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3019% below fair value

$0.63−0.05 (-7.36%)

Close on Nov 13, 2026Market cap $66.74MP/E –Yield –

Hyperfine gross margin

Gross margin is gross profit as a percentage of revenue.

Hyperfine's gross margin for the twelve months ending Sep 30, 2026 was 52.6%. For fiscal 2025 it was 49.8%, against 45.7% the year before. The highest annual figure on record is 49.8% in fiscal 2025.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	49.8%	+4.1
FY2024	Dec 31, 2024	45.7%	+2.6
FY2023	Dec 31, 2023	43.1%	+29.8
FY2022	Dec 31, 2022	13.3%	+91.3
FY2021	Dec 31, 2021	-78.0%	+84.2
FY2020	Dec 31, 2020	-162.2%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	56.7%	+3.0
Q2 FY2026	Jun 30, 2026	50.7%	+1.5
Q1 FY2026	Mar 31, 2026	50.7%	+9.4
Q4 FY2025	Dec 31, 2025	50.9%	+15.3
Q3 FY2025	Sep 30, 2025	53.8%	+1.4
Q2 FY2025	Jun 30, 2025	49.3%	−0.4
Q1 FY2025	Mar 31, 2025	41.3%	+0.2
Q4 FY2024	Dec 31, 2024	35.6%	−2.9
Q3 FY2024	Sep 30, 2024	52.4%	+4.1
Q2 FY2024	Jun 30, 2024	49.7%	+6.9
Q1 FY2024	Mar 31, 2024	41.1%	−2.7
Q4 FY2023	Dec 31, 2023	38.5%	+17.4
Q3 FY2023	Sep 30, 2023	48.2%	+18.9
Q2 FY2023	Jun 30, 2023	42.7%	+53.5
Q1 FY2023	Mar 31, 2023	43.8%	+38.3
Q4 FY2022	Dec 31, 2022	21.1%	+125.0
Q3 FY2022	Sep 30, 2022	29.3%	+120.4
Q2 FY2022	Jun 30, 2022	-10.8%	+16.9
Q1 FY2022	Mar 31, 2022	5.6%	+89.3
Q4 FY2021	Dec 31, 2021	-103.9%	–
Q3 FY2021	Sep 30, 2021	-91.1%	–
Q2 FY2021	Jun 30, 2021	-27.7%	–
Q1 FY2021	Mar 31, 2021	-83.7%	–